POSTER SESSION VI
Wednesday, March 11, 2009 — 1:00 PM - 4:00 PM
Hynes CC Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
16
Evaluation of Incomplete Tumor Regression Scores for Neoadjuvant Chemotherapy of Breast Cancer and Predictive Value of Immunohistology
(298)
HP Sinn, Z Elsawaf, P Schirmacher - University Hospital Heidelberg, Heidelberg, Germany
p53 Mutation Correlates with Molecular Profile and Outperforms p53 Immunohistochemistry in Predicting Response to Neo-Adjuvant Chemotherapy in Operable Early Stage Breast Cancer
(283)
JS Ross, CM Perou, E Slodkowska, MS Ross, AB Boguniewicz, EF McKenna, HJ Lawrence, M Royce, S Gluck - Albany Medical College, Albany, NY; U North Carolina, Chapel Hill, NC; XeNa Trialists and Roche Molecular Systems, Pleasanton, CA; U New Mexico, Albuquerque, NM; Miami U, Miami, FL
MammaPrint Predicts Survival in Small Breast Cancer Tumors
(287)
GA Seitz, AM Glas, P Roepmann, F de Snoo, L van't Veer - Klinikum Bamberg, Bamberg, Germany; Agendia PV, Amsterdam, Netherlands; Netherlands Cancer Institute, Amsterdam, Netherlands
Can Factors Evaluated in the Routine Pathologic Evaluation of Lymph Node-Negative Estrogen Receptor-Positive Stage I or II Invasive Breast Cancer Be Used To Predict the Oncotype DX Assay Recurrence Score?
(112)
J Auerbach, S Fineberg - Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
Expression of FOXA1, Estrogen Receptor Associated Transcription Factor, Correlates with Oncotype Dx Recurrence Score
(312)
MA Thorat, FO Ademuyiwa, H Nakshatri, S Badve - Indiana University, Indianapolis, IN
The Multigene Assay Oncotype Dx Is Unnecessary for Low Grade Invasive Breast Carcinoma
(296)
JF Simpson, I Mayer, J Means, S Serie, ME Sanders - Vanderbilt University Medical Center, Nashville, TN
Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
(214)
N Khilko, J Wang, DG Hicks, P Tang - Univ. of Rochester Medical Center, Rochester, NY; RTI Health Solutioon, Research Triangle Park, NC
Mammaglobin - Based Assays for Detection of Minimal Residual Mammary Cancer Will Miss All Metaplastic and Medullary Carcinomas
(279)
C Reyes, A Mejias, C Gomez-Fernandez, M Nadji - Univ. of Miami, Jackson Memorial Hospital and Sylvester Comprehensive Cancer Center, Miami, FL
Novel Biomarker To Aid in Differentiating Infiltrating Ductal Versus Infiltrating Lobular Carcinoma of the Breast
(208)
BVS Kallakury, GM Sheehan, CG Broustas, CE Sheehan, UN Kasid, JS Ross - Georgetown University Hospital, Washington, DC; Albany Medical College, Albany, NY
Feasibility and Potential Utility of IPX Cocktail Double Stain in Breast Cancer
(314)
PA Tsivis, D Coppola, B Babbin, D Tacha, MM Bui - Moffitt Cancer Center, Tampa; Physicians RightPath, Tampa; Biocare, Concord, NH
Evaluation of RT-PCR for Human Mammaglobin mRNA in Assisting the Diagnosis of Breast Cancer Pleural Effusion
(166)
F Fedeli, P Ferro, B Bacigalupo, MC Franceschini, V Fontana, P Dessanti, N Gorji, MP Pistillo, S Roncella - Sant'Andrea Hospital, La Spezia, Italy; "Sezione F. Lanzone" AIL, La Spezia, Italy; Comitato Assistenza Malati e Lotta Contro i Tumori, Sarzana, La Spezia, Italy; IST, Genova, Italy
Spectrum of Pathologic Findings in Magnetic Resonance Imaging-Guided Breast Core Biopsies
(330)
W Zeng, MK Sidawy - Georgetown University Hospital, Washington, DC
Pathologic Findings in MRI-Directed Needle Core Biopsies of the Breast in Patients with Newly Diagnosed Breast Cancer
(299)
KP Siziopikou, MA Cobleigh, G Solmos, P Gattuso, P Jokich - Rush University Medical Center, Chicago, IL
Magenetic Resonance Imaging of the Breast: Radiologic-Pathologic Correlation
(266)
J Obermeyer, N Wadhwani, D Bova, S Sarker, K Rychlik, A Salhadar, C Ersahin, PB Rajan - Loyola University Chicago Medical Center, Maywood, IL
Visualizing Internal Structures of the Breast in Thick-Sections Using X-ray Dark-Field Imaging
(203)
S Ichihara, M Ando, D Shimao, S Moritani, M Hasegawa, H Sugiyama - Nagoya Medical Center, Nagoya, Aichi, Japan; Tokyo University of Science, Noda, Chiba, Japan; Ibaraki Prefectural University of Health Science, Ami, Ibaraki, Japan; High Energy Accelerator Research Organization, Tsukuba, Ibaraki, Japan
Best Practice Guidelines for the Pathological Evaluation of Reduction Mammoplasty Specimens - A Surgical Conundrum
(210)
R Kanthan, JL Senger, R Chibbar - University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Delayed Formalin Fixation Effect on Breast Biomarkers
(215)
T Khoury, S Sait, G Wilding, R Chandrasekhar, N Daoud, S Kulkarni - Roswell Park Cancer Institution, Buffalo, NY
Biopsy Cavities in Breast Cancer Specimens: Impact on Quantitative RT-PCR Gene Expression Profiles and Recurrence Risk Assessment
(116)
FL Baehner, C Quale, C Pomeroy, D Cherbavaz, S Shak - UCSF, San Francisco, CA; Genomic Health, Inc, Redwood City, CA
Diagnosing Breast Cancer Using Multimodal Spectroscopic
(317)
Z Volynskaya, O Scepanovic, M Fitzmaurice, R Shenk, W Liu, L Galindo, RR Dasari, MS Feld - Massachusetts Institute of Technology, Cambridge, MA; Case Western Reserve University, Cleveland, OH; University Hospitals - Case Medical Center, Cleveland, OH
button next to any title to add to Itinerary Planner...
Add
